FitLife Brands Inc

FitLife Brands Inc(FTLF)股票分析

$8.000

-0.176 (-2.20%)收盤時

Loading chart…
最高
8.120
開盤
8.120
成交量加權均價
8.04
成交量
6.95K
市值
151.74M
最低
8.000
成交金額
55.85K
企業價值/稅息折舊攤銷前利潤(TTM)
7.55

FitLife Brands, Inc. is a developer and marketer proprietary nutritional supplements and wellness products for health-conscious consumers. It markets approximately 250 different products primarily online, through domestic and international GNC franchise locations as well as through various retail locations. It offers NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, and Metis Nutrition (together, NDS Products); iSatori, BioGenetic Laboratories, and Energize (together, the iSatori Products); Dr. Tobias, All Natural Advice, and Maritime Naturals (together, the MRC Products) and MusclePharm. Its NDS brand includes premium weight loss, sports nutrition, and general health products. Its PMD brand includes premium sports nutrition products. Its Nutrology brand included sports nutrition and general wellness products with an emphasis on natural, vegan, and organic ingredients. Its SirenLabs brand includes weight loss and sports nutrition products.

AI 分析 of FitLife Brands Inc (FTLF)

持有

Currently, FitLife Brands Inc (FTLF) is not a strong buy due to its low RSI of 37.37, indicating potential oversold conditions, and a significant year-to-date decline of 49.05%. Although there was a recent revenue growth of 65% year-over-year in Q2 2026, the company's gross margin has declined to 36.01%. The upcoming earnings report on November 16, 2026, could provide more clarity, but the current price of $8.03 and the forward P/E of 6.11 suggest caution as the stock is still underperforming.

估值指標

FitLife Brands Inc(FTLF)目前預期本益比為 6.26,5 年平均預期本益比為 7.67。

預期本益比

合理
5 年均值 P/E
7.67
目前P/E
6.26
高估
14.10
低估
1.24

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
5.63
目前EV/EBITDA
7.55
高估
10.22
低估
1.04

預期股價營收比

合理
5 年均值 P/S
0.93
目前P/S
0.68
高估
1.78
低估
0.09

事件時間軸

2026-04-01 (ET)

16:30:00

Major Averages Close Broadly Higher as Market Sentiment Improves

12:20:00

Major Averages Broadly Higher as Market Sentiment Improves

07:10:00

Legacy FitLife Reports Q4 Revenue of $25.9M

2025-11-13 (ET)

07:36:28

FitLife Brands Announces Q3 EPS of 9 Cents Compared to 21 Cents Last Year

2025-08-14 (ET)

07:03:17

FitLife Brands reports Q2 EPS 18c vs. 27c last year

資訊

FTLF 常見問題 —— 由 Alphio AI 解答

FitLife Brands, Inc. is a developer and marketer proprietary nutritional supplements and wellness products for health-conscious consumers. It markets approximately 250 different products primarily online, through domestic and international GNC franchise locations as well as through various retail locations. It offers NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, and Metis Nutrition (together, NDS Products); iSatori, BioGenetic Laboratories, and Energize (together, the iSatori Products); Dr. Tobias, All Natural Advice, and Maritime Naturals (together, the MRC Products) and MusclePharm. Its NDS brand includes premium weight loss, sports nutrition, and general health products. Its PMD brand includes premium sports nutrition products. Its Nutrology brand included sports nutrition and general wellness products with an emphasis on natural, vegan, and organic ingredients. Its SirenLabs brand includes weight loss and sports nutrition products. It operates in the Consumer Non-Cyclicals sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Currently, FitLife Brands Inc (FTLF) is not a strong buy due to its low RSI of 37.37, indicating potential oversold conditions, and a significant year-to-date decline of 49.05%. Although there was a recent revenue growth of 65% year-over-year in Q2 2026, the company's gross margin has declined to 36.01%. The upcoming earnings report on November 16, 2026, could provide more clarity, but the current price of $8.03 and the forward P/E of 6.11 suggest caution as the stock is still underperforming.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易